CytoDyn Cash Flow - Annual (OTCMKTS:CYDY)

Add to My Stocks
$0.62 $0.01 (1.59%) CYDY stock closing price Sep 19, 2018 (Closing)

The CytoDyn cash flow statement is one of the three reports that the company generates every quarter. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about CytoDyn profits and CytoDyn debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the CytoDyn stock analysis. CytoDyn generated $-26.73M cash from operating activities in 2017. CYDY decrease in investments stood at a value of $-0.01M for the latest year 2017.

View details of CytoDyn cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jun - May201720162015201420132012201120102009
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-2.85M3.13M4.27M1.92M----
Net Increase (Decrease) in Assets Liabilities-0.98M-6.27M6.94M-0.17M1.03M---0.19M-0.01M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net-0.34M4.31M2.99M-3.21M2.86M1.18M1.74M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.01M-0.01M-0.01M-----
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-----3.5M----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares19.53M38.11M1.14M13.69M-3.71M1.36M2.72M1.51M
Issuance (Repayment) of Debt Securities---------
Increase (Decrease) in Bank & Other Borrowings1.15M-0.78M7.48M-7.01M-0.07M-0.01M-0.06M-0.05M
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-1.8M-3.91M-0.42M-2.7M---0.23M-0.07M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year9.64M1.05M4.88M--1.03M---
Cash & Equivalents at Year End1.77M9.64M1.05M4.88M-----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

CytoDyn stock comparison chart provides an easy way to compare the stock price with peers along with details of CytoDyn stock price history.
The statement of cash flows can be categorized into three main sections:

  • CytoDyn has cash of $1.77M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the CytoDyn stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. CytoDyn lost $-26.73M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: CytoDyn used $-0.01M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $18.87M for CytoDyn. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For CytoDyn Cash Flow